Company Overview
Snapshot
Founded in January 2017 by Brad Cohen, Kyle Giddens, and Josh Chaim, medcase operates with 51–200 employees. The company has raised $4.1 million across two funding rounds from three investors. In November 2022, medcase signed a definitive agreement with NTT DATA to provide healthcare AI developers with a comprehensive solution for accessing, annotating, and labeling critical imaging data.
Business overview
medcase provides a global marketplace for on-demand, language-specific medical expertise across various specialties. Its platform enables clinicians to offer consulting and clinical services to interested parties worldwide. The company's services are utilized by contract research organizations, biotech, pharmaceutical, and artificial intelligence companies for applications including telehealth, data labeling, annotation, surveys, and interviews, operating within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Clinical Workflow.
Strategic signal
In November 2022, medcase entered into a definitive agreement with NTT DATA to offer healthcare AI developers a holistic solution for accessing, annotating, and labeling critical imaging data. This partnership signals medcase's strategic expansion into supporting AI development within healthcare, demonstrating its platform's utility beyond direct clinical consultation to facilitate advanced technological innovation in the medical field.
Company Intelligence Q&A
- What is medcase's primary offering?
- medcase provides a global marketplace that offers on-demand, language-specific medical expertise across all specialties, enabling clinicians to provide consulting and clinical services worldwide.
- When was medcase founded and by whom?
- medcase was founded in January 2017 by Brad Cohen, Kyle Giddens, and Josh Chaim.
- What significant partnership did medcase establish in late 2022?
- In November 2022, medcase signed a definitive agreement with NTT DATA to provide healthcare AI developers with a holistic solution for accessing, annotating, and labeling critical imaging data.
- Which investors participated in medcase's July 2022 funding round?
- This funding was part of a round that contributed to the company's total of $4.1 million raised across two funding rounds.
- What was a key development for medcase in July 2021?
- In July 2021, medcase secured funding from Sopris Capital and Firstime VC, which was highlighted as powering the next phase of healthcare innovations with its global marketplace of on-demand physicians.